Health Economics in Oncology: Addressing Financial Toxicity, Value-Based Care, and Equity
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Health Economics".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 334
Special Issue Editor
Special Issue Information
Dear Colleagues,
Recent advances in cancer prevention, diagnosis, and treatment have improved survival rates. However, these improvements have also led to rising costs that burden patients, families, and health systems. Financial toxicity is now recognized as a serious consequence of cancer care, affecting patients’ quality of life, treatment adherence, and long-term outcomes, even in countries with universal health coverage. This Special Issue welcomes original research and reviews on the economic aspects of oncology, including cost-effectiveness, financial disparities, value-based care, and policy strategies that improve affordability and equity. We are especially interested in studies that explore ways to reduce financial hardship, increase efficiency, and support informed decision-making throughout the process of cancer care. We also welcome the submission of articles that focus on underserved populations and global trends such as digital health tools or workforce-related policies. We aim to generate actionable insights that support both economic sustainability and improved patient outcomes in oncology.
Dr. Marcell Csanádi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- financial toxicity
- cost-effectiveness
- value-based care
- cancer care
- economic sustainability
- health policy
- treatment affordability
- underserved populations
- digital health
- oncology economics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
